Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

People with all types of psoriasis are more likely to have autoimmune diseases than those without psoriasis.

Wildfire air pollution is linked to more online searches and clinic visits for psoriasis in adults after a delay.

Psoriasis patients did not show more brain atrophy or small vessel disease than controls, but longer psoriasis duration was linked to more brain atrophy.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

The new gel for psoriasis is effective, stable, and easy to apply.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

Treating sheep and wild goats with specific medications and bathing sheep was 100% effective against a contagious skin disease caused by mites.

People with psoriasis have higher levels of Apelin-13 in their blood than healthy people.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

There are various tools available to help psoriasis patients manage their condition, but their effectiveness is unclear and they face issues like lack of financial support.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

Alopecia areata does not affect areas with psoriasis plaques.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Cholecystokinin may help reduce skin inflammation in psoriasis.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

Sebaceous gland atrophy and abnormal function may contribute to hair loss in psoriasis.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Some drugs for inflammation may cause psoriasis-like hair loss.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Hair restoration surgery can worsen psoriasis, so careful planning is needed.